GlassScriptPhysician profile
Christopher J Richards
NPI 1629362066
$64,220.95
in general payments reported to CMS, 2019-2025
6 companies · $19K in 2025
The $19K reported for 2025 was more than what 95% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.65 · 2023: $11K · 2024: $35K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $55K · Travel and Lodging: $7,843 · Food and Beverage: $1,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $54,712.00 |
| Travel and Lodging | $7,842.50 |
| Food and Beverage | $1,645.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $58,838.48 | 2023-2025 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $4,069.54 | 2024-2025 | |
| Electromed, INC. | $1,200.00 | 2024 | Smartvest |
| Verona Pharma, INC. | $92.28 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $20.65 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.